$30.21 Million in Sales Expected for Tellurian Inc. (NASDAQ:TELL) This Quarter

Wall Street brokerages expect Tellurian Inc. (NASDAQ:TELL) to announce sales of $30.21 million for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Tellurian’s earnings. The highest sales estimate is $49.50 million and the lowest is $12.90 million. Tellurian posted sales of $14.27 million during the same quarter last year, which suggests a positive year over year growth rate of 111.7%. The company is scheduled to issue its next quarterly earnings results on Friday, November 5th.

On average, analysts expect that Tellurian will report full-year sales of $87.37 million for the current financial year, with estimates ranging from $25.44 million to $145.80 million. For the next fiscal year, analysts forecast that the business will report sales of $505.36 million, with estimates ranging from $22.31 million to $2.03 billion. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Tellurian.

Tellurian (NASDAQ:TELL) last issued its quarterly earnings results on Tuesday, August 3rd. The oil and gas producer reported ($0.08) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.05) by ($0.03). The company had revenue of $25.35 million during the quarter, compared to analysts’ expectations of $21.69 million. Tellurian had a negative return on equity of 63.23% and a negative net margin of 173.31%.

TELL has been the topic of a number of analyst reports. Morgan Stanley dropped their price target on Tellurian from $8.00 to $7.00 and set an “equal weight” rating on the stock in a research note on Monday, August 23rd. Zacks Investment Research raised Tellurian from a “sell” rating to a “hold” rating in a research note on Tuesday, August 10th. B. Riley initiated coverage on Tellurian in a research note on Thursday, July 8th. They set a “buy” rating and a $8.00 target price on the stock. Wolfe Research lifted their target price on Tellurian from $5.00 to $7.00 and gave the company an “outperform” rating in a research note on Thursday, May 27th. Finally, Credit Suisse Group lowered their target price on Tellurian from $6.00 to $5.50 and set a “neutral” rating on the stock in a research note on Wednesday, August 11th. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $5.83.

Shares of TELL opened at $3.53 on Friday. The business’s 50-day moving average price is $3.20 and its 200 day moving average price is $3.14. The stock has a market capitalization of $1.52 billion, a P/E ratio of -13.58 and a beta of 2.72. Tellurian has a 1-year low of $0.68 and a 1-year high of $5.76.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Parametric Portfolio Associates LLC grew its stake in shares of Tellurian by 563.1% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 169,006 shares of the oil and gas producer’s stock valued at $786,000 after buying an additional 143,517 shares in the last quarter. Massmutual Trust Co. FSB ADV grew its stake in shares of Tellurian by 14.2% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 34,813 shares of the oil and gas producer’s stock valued at $162,000 after buying an additional 4,334 shares in the last quarter. Metropolitan Life Insurance Co NY grew its stake in shares of Tellurian by 199,595.5% in the 2nd quarter. Metropolitan Life Insurance Co NY now owns 87,866 shares of the oil and gas producer’s stock valued at $409,000 after buying an additional 87,822 shares in the last quarter. Millennium Management LLC grew its stake in shares of Tellurian by 11,085.4% in the 2nd quarter. Millennium Management LLC now owns 5,861,157 shares of the oil and gas producer’s stock valued at $27,254,000 after buying an additional 5,808,757 shares in the last quarter. Finally, MetLife Investment Management LLC grew its stake in shares of Tellurian by 70.5% in the 2nd quarter. MetLife Investment Management LLC now owns 114,765 shares of the oil and gas producer’s stock valued at $534,000 after buying an additional 47,463 shares in the last quarter. 29.08% of the stock is owned by institutional investors and hedge funds.

About Tellurian

Tellurian, Inc engages in producing natural gas and investing in natural gas projects. It develops a portfolio of natural gas production, LNG marketing, and infrastructure assets that includes an LNG terminal facility and an associated pipeline in southwest Louisiana. The company was founded by Charif Souki and Martin Houston in 1957 and is headquartered in Houston, TX.

Featured Article: What is an economic bubble?

Get a free copy of the Zacks research report on Tellurian (TELL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tellurian (NASDAQ:TELL)

Receive News & Ratings for Tellurian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tellurian and related companies with MarketBeat.com's FREE daily email newsletter.